Examining the Usage of Dopamine Blockers in OCD Patients

Completed

• Conditions: Obsessive Compulsive Disorder

• Registration Number: NCT00496925
• Lead Sponsor: Sheba Medical Center

Brief Summary

We examine the usage of Dopamine blockers in OCD patients. We want to examine their frequency of usage, compare the course of the disease between those who receive and those who do not receive Dopamine blockers, and efficacy of the treatment.

The study will be done in two stages: 1. Collecting information the usage of Dopamine blockers from 150 OCD patients' files. 2. interviewing 60-70 patients to see the difference those who receive and those who do not receive Dopamine blockers in their current severity of disease.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2007-07-04
• Study First Submitted QC: 2007-07-05
• Study First Posted: 2007-07-06
• Study Start: 2007-11
• Primary Completion: 2009-07
• Study Completion: 2009-07
• Status Verified: 2010-01
• Last Update Submitted: 2010-01-31
• Last Update Posted: 2010-02-02

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 63

Inclusion Criteria

• Patients over 18 years of age
• DSM-IV diagnosis of OCD
• Ability to understand patient information sheet, and consent to participate

Exclusion Criteria

• Current or past Psychotic or Bipolar disorder

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

Chaim Sheba Medical Center; 🇮🇱 Ramat-Gan, Israel